Many people already know that the hemp plant has a broad range of cannabinoids in it, such us: Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), etc. More well-known cannabinoids are CBD and THC, but recently research attention has caught studying one of the cannabinoids - Cannabigerol (CBG), one of the most expensive cannabinoids to produce. Researches have found CBG in a low concentration in mature cannabis flowers. CBG is like the other cannabinoids' ancestor, which means that all cannabinoids occur as CBG and ultimately convert to other cannabinoids like THC or CBD. CBD and CBG are both does not have psychoactive effects. According to various studies, both connect with the same receptors in our bodies and can have anti-inflammatory effects. Also, CBG can interact with many different receptors in our bodies more directly and effectively than CBD. There is still minimal research on CBG, but the studies show that using CBG can positively influence appetite loss, inflammatory bowel disease, bladder dysfunctions, glaucoma, bacterial infections, Huntington's disease, cancer. It must be remembered that CBG is still under research, and there is still much to be learned about it. However, the initial studies are quite promising.